The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Integra Plus
Ferrous Fumarate and Polysacchride Iron Vitamin Mineral Complex Supplement · FERROUS FUMARATE 62.5 mg/1; FERROUS ASPARTO GLYCINATE 62.5 mg/1; FOLIC ACID 1 mg/1; ASCORBIC ACID 210 mg/1; NIACIN 20 mg/1; THIAMINE MONONITRATE 5 mg/1; RIBOFLAVIN 5 mg/1; CALCIUM PANTOTHENATE 5 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; BIOTIN 300 ug/1 · Capsule · Oral · U.S. Pharmaceutical Corporation
NDC 52747-0712-10 · 40 BLISTER PACK in 1 BOX / 4 CAPSULE in 1 BLISTER PACK · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.0%chance of a new FDA shortage posting for ferrous fumarate and polysacchride iron vitamin mineral complex supplement (oral solid) in the next 90 days
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Ferrous Fumarate and Polysacchride Iron Vitamin Mineral Complex Supplement (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| U.S. Pharmaceutical Corporation | FERROUS FUMARATE 62.5 mg/1; FERROUS ASPARTO GLYCINATE 62.5 mg/1; FOLIC ACID 1 mg/1; ASCORBIC ACID 210 mg/1; NIACIN 20 mg/1; THIAMINE MONONITRATE 5 mg/1; RIBOFLAVIN 5 mg/1; CALCIUM PANTOTHENATE 5 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; BIOTIN 300 ug/1 | Aug 26, 2026 | Sep 2, 2026 |
| U.S. Pharmaceutical Corporation | FERROUS FUMARATE 210 mg/1; FERROUS ASPARTO GLYCINATE 300 ug/1; FOLIC ACID 5 mg/1; ASCORBIC ACID 62.5 mg/1; NIACIN 62.5 mg/1; THIAMINE MONONITRATE 1 mg/1; RIBOFLAVIN 20 mg/1; CALCIUM PANTOTHENATE 25 mg/1; PYRIDOXINE HYDROCHLORIDE 5 mg/1; BIOTIN 5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| U.S. Pharmaceutical Corporation | ASCORBIC ACID 210 mg/1; BIOTIN 300 ug/1; CALCIUM PANTOTHENATE 5 mg/1; FERROUS ASPARTO GLYCINATE 62.5 mg/1; FERROUS FUMARATE 62.5 mg/1; FOLIC ACID 1 mg/1; NIACIN 20 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; RIBOFLAVIN 5 mg/1; THIAMINE MONONITRATE 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Integra Plus — NDC 52747-0712-10," retrieved September 3, 2026, https://drugdashboards.com/drug/52747071210.
Free to cite with attribution — see how the data is put together.